Greenvale Capital LLP Viatris Inc Transaction History
Greenvale Capital LLP
- $1.52 Billion
- Q3 2024
Shares
2 transactions
Others Institutions Holding VTRS
# of Institutions
1,103Shares Held
934MCall Options Held
2.71MPut Options Held
2.4M-
Vanguard Group Inc Valley Forge, PA141MShares$1.78 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY92.7MShares$1.17 Billion0.02% of portfolio
-
State Street Corp Boston, MA63.1MShares$795 Million0.03% of portfolio
-
Chris Davis Davis Selected Advisers | Tucson, Az62.6MShares$789 Million4.18% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD48.8MShares$614 Million0.07% of portfolio
About Viatris Inc
- Ticker VTRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,212,669,952
- Market Cap $15.3B
- Description
- Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...